Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Clinical trial NCT03627091 · TERMINATED
Trial details
- NCT number
- NCT03627091
- Sponsor
- Shire
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-06
- Primary completion
- 2021-06-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.